Salinas, CA Breakthrough On Squamous Cell Lung Cancer Treatmentby Richard Kuehn on 09/11/12
I've written many times on my blog about the exciting research being done on human DNA which could one day result in different drugs being prescribed for different patients based upon their individual genetic make-up. A major drug study was just released that looked at the genetics of a common type of lung cancer and the researchers found that more than half of the tumors have mutations which might be treated by new drugs that are already in development or that could be easily manufactured. That's a huge break-through for the tens of thousands of Americans which have squamous cell lung cancer. "This is a disease where there are no targeted therapies," said Dr. Matthew Meyerson of the Dana-Farber Cancer Institute in Boston, referring to modern drugs that attack genetic abnormalities. He is a lead author of a paper on the study, with more than 300 authors, which was published online in the journal Nature on Sunday. "What we found will change the landscape for squamous cell carcinoma," Dr. Meyerson said. "I think it gives hope to patients." The study comes out of the Cancer Genome Atlas, which I have written about before on my blog. It's a massive project sponsored by the National Institutes of Health and gives hope to people with many diseases that new treatments will be found. Although it will be a time consuming process, one day we may have new treatments for literally hundreds of diseases using personalized medicine.